Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: A look at the clinical and pharmacological evidence
- 1 August 2009
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 123 (2) , 178-186
- https://doi.org/10.1016/j.pharmthera.2009.03.019
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Incidence and Predictors of Drug-Eluting Stent Thrombosis During and After Discontinuation of Thienopyridine TreatmentCirculation, 2007
- Clopidogrel Withdrawal Is Associated With Proinflammatory and Prothrombotic Effects in Patients With Diabetes and Coronary Artery DiseaseDiabetes, 2006
- Aspirin Withdrawal and Acute Lower Limb IschemiaAnesthesia & Analgesia, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Discontinuing chronic aspirin therapy: Another risk factor for stroke?Annals of Neurology, 2001
- Effects of Acetyl Salicylic Acid Therapy on an Experimental Thrombosis Induced by Laser BeamThrombosis Research, 2000
- AspirinCirculation, 2000
- Thromboembolic Complications Several Days After a Single-Dose Administration of AspirinThrombosis Research, 1998
- Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatmentBlood Coagulation & Fibrinolysis, 1996
- Inter-individual variations of the effect of low dose aspirin regime on platelet cyclooxygenase activityThrombosis Research, 1994